Sujatha is responsible for establishing Orphalan’s US operations and leading the product development for US products. She is also responsible for implementing a business development strategy to identify and champion opportunities from the US.
Sujatha, has over 25 years of Pharmaceutical industry experience in R & D, Regulatory Affairs, Operations and Business Development at Baxter, Avanos and Renalysis. She has a proven track record across multiple functions, bringing a hands-on approach to new product development strategic planning and execution.
At Renalysis, Sujatha defined and implemented the R & D, manufacturing, clinical and regulatory strategy, recruiting and developing the team, setting up laboratories in Chicago and building and gaining approval of a manufacturing plant in China. Sujatha has experience in a wide range of therapeutic areas, including ophthalmology, renal, oncology, immunology and neurology therapeutic. She is on the advisory board for Center for Regenerative Medicine. at Northwestern. University. She has a. PhD. in Chemical Engineering from Stevens Institute of Technology and postdoctoral training from Massachusetts Institute of Technology.